Dasatinib
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP (NCT04155411) | Shenzhen Second People's Hospital | 2019-12-01 |
| Dasatinib In Waldenström Macroglobulinemia (NCT04115059) | Jorge J. Castillo, MD | 2019-11-04 |
Track Dasatinib automatically
Every clearance here is in the API, with alerts when new ones post.